Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
MyoGene Bio
https://www.myogenebio.com/
Therapeutics
A privately held biotech company based in San Diego, CA dedicated to developing next-generation genetic therapies for Duchenne and other muscle diseases. The company's lead program is a gene editing therapy for Duchenne muscular dystrophy.
Leadership & Board
Current Number of Employees
5
Current LinkedIn Followers
904
Latest Estimated Valuation
Estimated Valuation
―
Estimated Valuation
―
Total Amount Raised
$400K
Total Amount Raised
$400K
Total Funding Rounds
1
Total Funding Rounds
1
Latest Funding Amount
$400K
Latest Funding Amount
$400K
Latest Funding Round
Investment
Latest Funding Round
Investment
Post-Money Valuation
―
Post-Money Valuation
―
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 04, 2025
Investment
$400.00K
―
Investors
Investor Name
Funding Round
Parent Project Muscular Dystrophy
Investment
Duchenne UK
Investment
How Women Invest
Investment
Related News and Analysis
Newsela Highlights AI Assistant and New K–5 Literacy Content Ahead of Back-to-School 2026
2h ago
NEWSE
Mindtickle Highlights Agentic AI Strategy in Revenue Enablement
2h ago
MINDT
Alkira Highlights Programmable Approach to Multi-Cloud Network Modernization
2h ago
ALKIR
LeoLabs Expands Hiring to Support Growth in Defense and Space Sensing
2h ago
LEOLA
TrustArc Emphasizes AI Prompt Strategy to Enhance Privacy Workflow Efficiency
2h ago
TRU2M
TrustArc Targets Displacement of Legacy Privacy Contracts
2h ago
TRU2M
Avathon Showcases Defense-Focused AI Maintenance and Manufacturing Capabilities at RIMPAC 2026
2h ago
AVATH
Avathon Targets Defense Opportunities at AFLCMC Life Cycle Industry Days
2h ago
AVATH
TaxGPT Emphasizes Human Judgment in AI-Driven Tax Research
2h ago
TAXGP
AI Skills Emerge as Strategic Differentiator in Accounting Workflows
2h ago
FLOQA
Show More
You need to enable JavaScript to run this app.